{"schema_version":"secwatch.filing_event.v1","accession":"0001628280-25-043293","form_type":"8-K","ticker":"INDV","cik":"0001625297","company_name":"Indivior Pharmaceuticals, Inc.","filed_at":"2025-10-01T23:59:59+00:00","discovered_at":"2026-05-14T18:02:39.965451+00:00","generated_at":"2026-05-17T05:05:32.568128+00:00","sec_items":["7.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.65,"confidence":"high","headline":"Indivior proposes redomiciliation to Delaware via new US parent IPI","bullets":["Each Indivior PLC share exchanged for one share of new Delaware corporation Indivior Pharmaceuticals, Inc. (IPI).","Timeline: shareholder circular mid-Nov 2025, EGM early Dec 2025, effective late Jan 2026.","Scheme requires approval by 75% in value and majority in number of shareholders voting at EGM.","No additional equity raised; IPI stock will trade on Nasdaq under symbol INDV.","Proposed change aims to expand US capital markets presence and simplify governance."],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-25-043293","json":"https://secwatch.observer/filing/0001628280-25-043293.json","markdown":"https://secwatch.observer/filing/0001628280-25-043293.md","text":"https://secwatch.observer/filing/0001628280-25-043293.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1625297/000162828025043293/0001628280-25-043293-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1625297/000162828025043293/indv-20251001.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T05:05:32.568128+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}